Pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report

Malignant mesothelioma is an aggressive cancer associated with prior exposure to asbestos and dismal prognosis. Immune checkpoint inhibitor therapy is currently approved by the Food and Drug Administration for pre-treated malignant pleural mesothelioma. We describe a 75-year-old patient with dissemi...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Transl Lung Cancer Res
Главные авторы: Schiopu, Sanziana R. I., Käsmann, Lukas, Schönermarck, Ulf, Fischereder, Michael, Grabmaier, Ulrich, Manapov, Farkhad, Rauch, Josefine, Orban, Martin
Формат: Artigo
Язык:Inglês
Опубликовано: AME Publishing Company 2021
Предметы:
Case Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7947381/
https://ncbi.nlm.nih.gov/pubmed/33718042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-1095
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы